Full-Time

Associate Director

Sales Training

Posted on 9/15/2025

Celgard

Celgard

201-500 employees

High-performance membranes for energy storage

No salary listed

Morrisville, NC, USA

Hybrid

Hybrid work model with some in-office presence required.

Category
Sales & Account Management
Required Skills
Word/Pages/Docs
Marketing
Excel/Numbers/Sheets
Requirements
  • Bachelor’s degree from an accredited university
  • At least 5 years of relevant pharmaceutical industry experience in Training with a focus on Rare Disease or Nephrology, Specialty Sales and/or Marketing.
  • Strong organizational skills; conscientious in attention to detail.
  • Excellent written and verbal communication skills
  • Exceptional presentation/facilitation skills
  • High level of professionalism and the ability to excel in a team environment.
  • Demonstrated analytical and problem-solving skills
  • Ability to self-motivate, work independently in a dynamic, fast-paced environment with shifting priorities
  • High clinical affinity and ability to master new clinical areas.
  • Ability to work in a cross functional and matrix environment.
  • Demonstrated ability to recommend learning solutions supporting a culture of continuous learning.
  • Proven success at performing responsibilities with a high degree of flexibility, objectivity, discretion, appropriate demeanor, and professionalism.
  • Expertise with key software (e.g. MS PowerPoint, MS Word, MS Excel, Outlook, etc.) and LMS platforms, (ACTO, VEEVA, Workday).
  • Willingness to travel up to 25% of the time.
Responsibilities
  • Develop and implement learning and development solutions that meet the organization’s business goals, aligning sales training initiatives with business strategies.
  • Partner with cross functional teams (Marketing, Field Sales Management, Sales Operations, Medical, etc.) to build and provide training to support corporate strategy.
  • Design, execute and facilitate National/Regional Sales Meeting training workshops.
  • Conduct field personnel needs assessments for Regional Business Directors (RBDs), Regional Sales Directors (RSDs), Rare Disease Account Managers (RDAMs) and Territory Account Managers (TAMs).
  • Serve as a subject matter expert and product/disease state lead.
  • Act as a resource for the field force by actively participating in all sales meetings.
  • Conduct routine field rides with Rare Disease Account Managers (RDAMs) and Territory Account Managers (TAMs), providing coaching and written feedback as required.
  • Manage training projects through the Medical, Legal and Regulatory review process.
  • Design, develop and deliver training curriculum and content which may include disease state, clinical, strategic and/or skill-based training.
  • Manage vendors when designing and developing training content.
  • Manage classroom environment in a manner that allows for adult learning and clinical/sales proficiency.
  • Manage training programs with a focus on sales and leadership development.
  • Develop and deliver sales and product training curricula supporting all commercial teams (Current inline products - Envarsus XR®/Tarpeyo®).
  • Build, facilitate and lead cross-training initiatives for Training Managers, Field Training Managers and Sr. TAMs for all commercial selling teams.
  • Partner with Sr. Director, Training Manager(s) and other business stakeholders to standardize and/or harmonize training processes across pharmaceutical/healthcare organizations.
  • Manage all aspects of the Initial Sales Training program, including prework, live/virtual classroom, and post-training learning. Facilitate live and virtual training sessions of varied sizes.
  • Create and manage all sales training materials, including eLearning modules, audio-visual materials, presentations, etc.
  • Curate and manage training content across multiple learning platforms ensuring compliance adherence.
  • Support, learning, performance and talent development as needed across the organization.
  • With Sr. Director, Training and Talent Development, develop metrics to assess and drive improvement for all sales training programs and administer any needed assessments to evaluate trainee knowledge and performance.
  • Collaborate with Talent Development, Human Resources and Functional Department Heads to identify, evaluate, build and deliver skill-based training supporting unique needs of emerging, first and second-line leaders.
  • Assist product manager(s) in developing new product launch training programs, go-to-market strategy, continuing sales training curricula, and marketing materials used by RDAMs and TAMs.
  • Develop and present or facilitate advanced product and sales training, building upon individual current knowledge and experience.
  • Research and review medical articles and studies, general sales training materials, and market information to evaluate suitability and update training programs, as needed.
  • Stay current with medical trends to implement the latest market and clinical trends into the sales training programs.
  • Attend training-focused conferences to keep abreast of new training trends and techniques for developing leaders and improving sales skills.
  • Adhere to and ensure compliance with the Veloxis Code of Conduct, all Company policies, rules, procedures, and Compliance standards as set forth.
  • Collaborate with the Marketing Review Committee (MRC) and manage the review process ensuring messaging and training materials are compliant and approved.
  • Ongoing sales training in collaboration with marketing on competitive activity and defense tactics.
  • Responsible for project management and logistics of in-house new hire training, including prework, LMS system, testing, development of participant workbooks, classroom presentations, and ordering any required materials.
  • Develop training interactions and workshops for National Sales Meetings, Mid-Year Meetings, and POAs, as needed.
Desired Qualifications
  • 4+ years of corporate-based sales training or field training experience preferred

Celgard makes and sells high-performance membrane materials and thin separators used inside batteries, as well as fabrics for outdoor apparel and medical PPE. The membranes sit between battery electrodes to prevent contact while allowing ions to pass, enabling safe and efficient operation in lithium-ion and other chemistries. The company stands out through its Asahi Kasei Group affiliation and strategic alliances (such as with Æsir Technologies) to pursue new battery chemistries, while expanding manufacturing capacity. Its goal is to provide reliable membranes and protective fabrics at scale to support safer, longer-lasting energy storage and protective textiles, and to drive industry growth through collaborations.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Charlotte, North Carolina

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Charlotte plant expansion adds 100 jobs, boosts LIB separator capacity for EVs.
  • Asahi Kasei invests in Hipore wet-process coating lines at Charlotte site.
  • Proven separators serve CATL, Panasonic in high-performance EV, ESS applications.

What critics are saying

  • CATL's in-house separators capture 39% EV market, cut Celgard revenue 10-15% by 2027.
  • SK Innovation, Toray wet-process tech displaces dry-process, erodes share in 12 months.
  • Solid-state batteries from Toyota, QuantumScape eliminate separators by 2028.

What makes Celgard unique

  • Celgard specializes in solvent-free dry-process microporous membranes for lithium-ion batteries.
  • Global facilities in USA, China anchor manufacturing for EV battery separators.
  • Strategic alliances with Æsir, Lithion, C4V target Ni-Zn, LFP, BM-LMP batteries.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Company News

Yahoo Finance
Jan 29th, 2024
Celgard and Æsir Technologies Forge Strategic Alliance to Drive Industry Innovation in Nickel-Zinc, Zinc-Air and Lithium-Zinc Batteries

Together, Celgard and Æsir will collaborate on joint research projects to further develop high-technology next-generation Nickel-Zinc (Ni-Zn), Zinc-Air (Zn-Air), Lithium-Zinc (Li-Zn) and Sodium-Zinc (Na-Zn) batteries used primarily in aviation, data centers, telecom, energy infrastructure and electric vehicle (EV) charging applications.

Plant Services
Nov 30th, 2023
Celgard expands North Carolina manufacturing plant to support electric vehicle supply chain

Celgard, LLC has announced plans to expand its manufacturing facility in Charlotte, North Carolina, generating 100 new jobs in the process.

PR Newswire
Oct 31st, 2023
Celgard Charlotte Manufacturing Facility To Expand Battery Separator Capacity And Create New Jobs

Celgard to expand facilities, workforce and product portfolio to better serve the EV battery separator supply chain. Post thisThe Biden-Harris Administration and the U.S. Department of Energy (DOE) have identified the domestic U.S. battery market as a critical supply chain focus area for the nation. Investments in Celgard's Charlotte plant will allow the company to expand existing infrastructure to quickly meet demand of the lithium-ion battery (LIB) separator supply chain and domestic customers.Celgard manufactures dry-process membrane separator also used in vehicle electrification. The company already has a skilled employee base capable of applying technical coatings to base film shipped from Hipore™ sister locations and completing finishing steps required to meet customer specifications

Tamarindo
Jun 13th, 2023
Celgard & Lithion Battery form battery storage alliance | Tamarindo

US-headquartered Celgard, a subsidiary of Polypore International, has formed a strategic alliance with Lithion Battery, whereby the two companies will undertake joint development of battery separators for lithium-ion cells for energy storage systems and microgrids.

PR Newswire Asia
Jun 7th, 2023
Celgard Takes Another Step In Energy Storage Growth As It Forms Strategic Alliance With Lithion Battery For Next-Generation Battery Cells

CHARLOTTE, N.C., June 7, 2023 /PRNewswire/ -- Celgard, LLC (Celgard), a subsidiary of Polypore International, LP (Polypore), is pleased to announce a newly formed strategic alliance with Lithion Battery, Inc. (Lithion), whereby the two companies will undertake joint development of battery separators for next generation lithium-ion cells with Lithium Iron Phosphate (LFP) cathode material. Through this collaborative effort, the companies will meet the ever-growing demand of supplying consistent power to those in need with energy storage systems (ESS) for uses such as micro-grid power applications. The cells could also be deployed in medical tools and military and industrial markets, where Celgard has been providing separator solutions for decades.

INACTIVE